Drug-Drug Interaction (DDI) of Eslicarbazepine Acetate with Antiepileptic Drugs

被引：0
|
作者：
Blum, David
Nunes, Teresa
Maier, Gary
Versavel, Mark
Zummo, Jacqueline
Kharidia, Jahnavi
Soares-da-Silva, Patricio
机构：
来源：
NEUROLOGY | 2011年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A287 / A287
页数：1
相关论文
共 50 条
  • [41] USING REAL WORLD EVIDENCE (RWE) TO ASSESS DRUG-DRUG INTERACTION (DDI) BETWEEN PAXLOVID AND THE TOP 100 PRESCRIBED DRUGS IN THE US
    Gerhart, J.
    Draica, F.
    Benigno, M.
    Sidhu, G.
    Atkinson, J.
    Reimbaeva, M.
    Francis, D.
    Baillon-Plot, N.
    Damle, B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S5 - S5
  • [42] DSIL-DDI: A Domain-Invariant Substructure Interaction Learning for Generalizable Drug-Drug Interaction Prediction
    Tang, Zhenchao
    Chen, Guanxing
    Yang, Hualin
    Zhong, Weihe
    Chen, Calvin Yu-Chian
    IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS, 2024, 35 (08) : 10552 - 10560
  • [43] Pharmacokinetics and drug interactions of eslicarbazepine acetate
    Bialer, Meir
    Soares-da-Silva, Patricio
    EPILEPSIA, 2012, 53 (06) : 935 - 946
  • [44] A review of the drug-drug interactions of the new antiepileptic drug brivaracetam
    Moseley, Brian
    Kervyn, Sophie
    Nicolas, Jean-Marie
    Stockis, Armel
    NEUROLOGY, 2017, 88
  • [45] A REVIEW OF THE DRUG-DRUG INTERACTIONS OF THE NEW ANTIEPILEPTIC DRUG BRIVARACETAM
    Moseley, B. D.
    Kervyn, S.
    Nicolas, J. M.
    Stockis, A.
    EPILEPSIA, 2016, 57 : 32 - 33
  • [46] SSF-DDI: a deep learning method utilizing drug sequence and substructure features for drug-drug interaction prediction
    Zhu, Jing
    Che, Chao
    Jiang, Hao
    Xu, Jian
    Yin, Jiajun
    Zhong, Zhaoqian
    BMC BIOINFORMATICS, 2024, 25 (01)
  • [47] DRUG-DRUG INTERACTION (DDI) ASSESSMENT TO GUIDE OPTIMAL USE OF HEPATITIS C (HCV) ANTIVIRALS WITH IMMUNOSUPPRESSANTS
    Barve, Avantika
    Xia, Binfeng
    Einolf, Heidi
    Xu, Lucy
    Zhang, Tao
    Kohler, Sven
    Junge, Guido
    Lopez, Patricia M.
    Sun, Haiying
    TRANSPLANT INTERNATIONAL, 2013, 26 : 198 - 198
  • [48] APPLICATION OF PHYSIOLOGICALLY BASED PHARMACOKINETIC MODEL (PBPK) TO PREDICT PH-DEPENDENT DRUG-DRUG INTERACTION (DDI) FORWEAK BASE DRUGS (WBDS)
    Dong, Z.
    Wu, F.
    Zhao, P.
    Lee, S. -C.
    Zhang, L.
    Seo, P.
    Zhang, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S27 - S27
  • [49] Evaluation of the drug-drug interaction (DDI) potential between elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and atorvastatin
    Custodio, Joseph
    West, Steve
    Sengupta, Devi
    Zari, Arian
    Humeniuk, Rita
    Ling, Kah Hiing
    Fordyce, Marshall
    Kearney, Brian
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [50] Clustering based drug-drug interaction networks for possible repositioning of drugs against EGFR mutations: Clustering based DDI networks for EGFR mutations
    Munir, Anum
    Elahi, Sana
    Masood, Nayyer
    COMPUTATIONAL BIOLOGY AND CHEMISTRY, 2018, 75 : 24 - 31
12345